Vaishampayan, U. N., Tomczak, P., Muzaffar, J., Winer, I. S., Rosen, S. D., Hoimes, C. J., … Velcheti, V. (2022). Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Vaishampayan, Ulka N., Piotr Tomczak, Jameel Muzaffar, Ira Seth Winer, Seth David Rosen, Christopher J. Hoimes, Aman Chauhan, et al. “Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Vaishampayan UN, Tomczak P, Muzaffar J, Winer IS, Rosen SD, Hoimes CJ, et al. Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Vaishampayan, Ulka N., et al. “Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Vaishampayan UN, Tomczak P, Muzaffar J, Winer IS, Rosen SD, Hoimes CJ, Chauhan A, Spreafico A, Lewis KD, Bruno DS, Dumas O, McDermott DF, Strauss JF, Chu QS, Gilbert L, Chaudhry A, Graham JR, Boni V, Ernstoff MS, Velcheti V. Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1. JOURNAL OF CLINICAL ONCOLOGY. 2022.